US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Corgi Genomics & Precision Medicine ETF

38.36

+0.63001.67%

Volume:2K

Turnover:88.79K

Market Cap:2.88M

PE:- -

High:38.36

Open:37.77

Low:37.77

Close:37.73

52wk High:38.70

52wk Low:23.88

Shares:75.00K

Float Shares:75.00K

Volume Ratio:0.64

T/O Rate:3.11%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Scholar Rock price target raised to $84 from $76 at BMO Capital

Cellectis pivots to in vivo gene editing and exits key CAR-T programs

Cellectis Announces Strategic Transformation To In Vivo Gene Editing Company

Vertex Minerals Revises Timeline for Proposed Securities Issue

Telix Wins FDA Nod for First FET-PET Glioma Imaging Drug Pixclara

Gap, Quanta, Thermo Fisher, LAC, First Solar Trending

Scholar Rock announces FDA approval of isembyld

Agilent Technologies Inc. Stock Outperforms Competitors on Strong Trading Day

IntegraGen receives rival takeover bids amid court‑ordered restructuring

Pharming wins FDA nod to extend Joenja use to younger APDS children

Vertex Minerals Confirms Reward Gold Mine Resource After ASX‑Driven Update

Analysts Offer Insights on NA Companies: Expeditors International (EXPD) and Illumina (ILMN)

Vertex Pharma EVP Jasper Van Grunsven Files Initial Beneficial Ownership Statement

Fortrea Reinstates Knoblauch as CFO After Legal Dispute with Former Employer

Bank of America Reveals 5.22% Indirect Stake in Qiagen

Thermo Fisher Coverage Assumed by UBS at Buy vs Previous Rating of Neutral

UBS Adjusts Guardant Health Price Target to $225 From $175, Maintains Buy Rating

MT Newswires Live

Thermo Fisher upgraded to Buy from Neutral at UBS

Steris PLC Stock Underperforms Tuesday When Compared to Competitors

Structure weakness ‘disconnected’ from underlying data, says Jefferies

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigeractivity.com/stock/GNMX/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"GNMX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GNMX\",,,,,undefined,":{"symbol":"GNMX","market":"US","secType":"STK","nameCN":"Corgi Genomics & Precision Medicine ETF","latestPrice":38.36,"timestamp":1791219285947,"preClose":37.73,"halted":0,"volume":2329,"delay":0,"changeRate":0.016697588126159624,"floatShares":75000,"shares":75000,"eps":0,"marketStatus":"Trading","change":0.63,"latestTime":"10-05 13:03:48 EDT","open":37.77,"high":38.36,"low":37.77,"amount":88791.77418000001,"amplitude":0.015637,"askPrice":38.51,"askSize":1000,"bidPrice":38.45,"bidSize":1000,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1791230400000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1302235200000,"exchange":"CBOE","adjPreClose":37.73,"nav":37.32,"aum":2799000,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":37.73,"preClose":37.73,"latestTime":"16:10 EDT","volume":6,"amount":226.38,"timestamp":1790971804746,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.642007,"impliedVol":0.0707,"impliedVolPercentile":0.2396},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GNMX\",,,,,undefined,":{"symbol":"GNMX","floatShares":75000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.642007,"shares":75000,"dividePrice":0,"high":38.36,"amplitude":0.015637,"preClose":37.73,"low":37.77,"week52Low":23.88,"pbRate":"--","week52High":38.7,"institutionHeld":0,"latestPrice":38.36,"eps":0,"divideRate":0,"volume":2329,"delay":0,"ttmEps":0,"open":37.77,"prevYearClose":25.56,"prevWeekClose":37.73,"prevMonthClose":38.3481,"prevQuarterClose":38.3481,"fiveDayClose":38.0549,"twentyDayClose":35.2788,"sixtyDayClose":31.0031},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GNMX\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GNMX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GNMX\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GNMX\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2667134663","title":"Scholar Rock price target raised to $84 from $76 at BMO Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2667134663","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667134663?lang=en_us&edition=fundamental","pubTime":"2026-09-14 19:36","pubTimestamp":1789385772,"startTime":"0","endTime":"0","summary":"BMO Capital raised the firm’s price target on Scholar Rock (SRRK) to $84 from $76 and keeps an Outperform rating on the shares. The FDA approval of...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/scholar-rock-price-target-raised-to-84-from-76-at-bmo-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/scholar-rock-price-target-raised-to-84-from-76-at-bmo-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IBB","TECB","BMED","LABU","IEIH","THNR","SYNB","GNMX","XLVX","IYH","NVIB","PINK","MEDI","BBP","MRNY","BK4585","IBRN","BK4139","IDNA","LFSC","MRNX","SRRK","RSPH","BK4588","GDOC","PSCH","FRTY","TBXU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667376655","title":"Cellectis pivots to in vivo gene editing and exits key CAR-T programs","url":"https://stock-news.laohu8.com/highlight/detail?id=2667376655","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667376655?lang=en_us&edition=fundamental","pubTime":"2026-09-14 15:15","pubTimestamp":1789370144,"startTime":"0","endTime":"0","summary":"Cellectis SA ( ($FR:ALCLS) ) has provided an announcement. Cellectis has approved a strategic shift to focus on in vivo gene editing, advancing two...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cellectis-pivots-to-in-vivo-gene-editing-and-exits-key-car-t-programs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cellectis-pivots-to-in-vivo-gene-editing-and-exits-key-car-t-programs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["WDNA","HELX","SYNB","IDNA","GNMX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667653981","title":"Cellectis Announces Strategic Transformation To In Vivo Gene Editing Company","url":"https://stock-news.laohu8.com/highlight/detail?id=2667653981","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667653981?lang=en_us&edition=fundamental","pubTime":"2026-09-14 14:40","pubTimestamp":1789368000,"startTime":"0","endTime":"0","summary":"Cellectis to advance two lead in vivo programs .HEAL-101 and .HEAL-201 in severe dyslipidemias with preliminary Phase 1 data planned in H2 2027 and H1 2028, respectivelyTransformation supported by con","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/14/3360712/0/en/cellectis-announces-strategic-transformation-to-in-vivo-gene-editing-company.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4156","SYNB","IDNA","GNMX","HEAL","WDNA","NC","BK4139","CLLS","HELX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667635488","title":"Vertex Minerals Revises Timeline for Proposed Securities Issue","url":"https://stock-news.laohu8.com/highlight/detail?id=2667635488","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667635488?lang=en_us&edition=fundamental","pubTime":"2026-09-14 07:40","pubTimestamp":1789342824,"startTime":"0","endTime":"0","summary":"Vertex Minerals Ltd. ( ($AU:VTX) ) has provided an update. Vertex Minerals Ltd. has updated its proposed securities placement timetable, revising t...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vertex-minerals-revises-timeline-for-proposed-securities-issue?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vertex-minerals-revises-timeline-for-proposed-securities-issue?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0320765992.SGD","LU1585245621.USD","BK4585","LU0109394709.USD","LU1674673691.USD","GNMX","IE00B2B36J28.USD","LU0889565916.HKD","LU1559883803.SGD","IE00B4R5TH58.HKD","IE00BJJMRZ35.SGD","LU1815336091.USD","LU0432979614.USD","IDNA","SG9999001176.SGD","IE00BJT1NW94.SGD","VRTX","LU2468319806.SGD","BBH","VERX","BK4588","LU2362541273.HKD","BK4109","LU0079474960.USD","LU0234570918.USD","IE00B19Z9P08.USD","SGXZ57979304.SGD","BK4532","LU0757428866.USD","LU0417517546.SGD","BIB","IE0009355771.USD","PBE","TBXU","IBBQ","LU0061475181.USD","LU0058720904.USD","SG9999001176.USD","LU0566484027.USD","MTX","LU1674673428.USD","LU2462157665.USD","IE00BZ9MQY76.HKD","LU1430594728.SGD","LU1093756325.SGD","IE00B894F039.SGD","LU0256863811.USD","BK4533","IBB","LU2089984988.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667635862","title":"Telix Wins FDA Nod for First FET-PET Glioma Imaging Drug Pixclara","url":"https://stock-news.laohu8.com/highlight/detail?id=2667635862","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667635862?lang=en_us&edition=fundamental","pubTime":"2026-09-14 06:54","pubTimestamp":1789340092,"startTime":"0","endTime":"0","summary":"The latest update is out from Telix Pharmaceuticals ( ($AU:TLX) ). Telix Pharmaceuticals has secured U.S. FDA approval for Pixclara, the first FET-...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/telix-wins-fda-nod-for-first-fet-pet-glioma-imaging-drug-pixclara?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/telix-wins-fda-nod-for-first-fet-pet-glioma-imaging-drug-pixclara?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BMED","TECB","BBP","IYH","RSPH","MRNY","BK4139","LFSC","IEIH","XLVX","LABU","FET","GDOC","FRTY","GNMX","BK4585","BK4179","TBXU","PINK","SYNB","IBB","MRNX","NVIB","MEDI","TLX","PSCH","IDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666060795","title":"Gap, Quanta, Thermo Fisher, LAC, First Solar Trending","url":"https://stock-news.laohu8.com/highlight/detail?id=2666060795","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666060795?lang=en_us&edition=fundamental","pubTime":"2026-09-12 17:01","pubTimestamp":1789203687,"startTime":"0","endTime":"0","summary":"Analysts are intrested in these 5 stocks: ( ($GAP) ), ( ($PWR) ), ( ($TMO) ), ( ($LAC) ) and ( ($FSLR) ). Here is a breakdown of their recent","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/weekend-updates/gap-quanta-thermo-fisher-lac-first-solar-trending?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/weekend-updates/gap-quanta-thermo-fisher-lac-first-solar-trending?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FSLR","TMED","BK4548","LU0823414478.USD","BK4141","LU0154245673.USD","LU0823421416.USD","CTEC","BK4535","LU1280957306.USD","IE00B4R5TH58.HKD","LU0251131958.USD","LU0096362180.USD","GNMX","ICLN","IE0034235188.USD","LU2249611893.SGD","BK4581","LITP","LU1670627923.USD","LU2125910336.SGD","BK4519","LU0708994859.HKD","LU2125909916.SGD","IE00BQXX3D17.EUR","LU0823416689.USD","IE00B19Z9505.USD","LU2125909247.SGD","BK4533","LU0154245756.USD","LU1057294990.SGD","BK4168","BK4596","LU0882574055.USD","LU2764262908.HKD","LU2543165471.USD","LU2720916845.USD","LU0323239441.USD","BK4534","LU0011850046.USD","LU2023250504.SGD","IE00B3CCJ633.GBP","LU1623119135.USD","LU0029864427.USD","LU1988902786.USD","LU2092937221.SGD","LU2764263039.SGD","LU2112291526.USD","LU0342679015.USD","LU1989771016.USD","LU1548497426.USD","LU0557290698.USD","LU1720051017.SGD","IE0009355771.USD","LU0070302665.USD","LU1992135472.HKD","LU2473716301.USD","IE00B19Z8W00.USD","TAN","IE00BJT1NW94.SGD","LU1854104046.USD","IE00B2PGVK34.USD","LU1791710400.SGD","LU0323240290.USD","LU1803068623.USD","VCLN","LU0114720955.EUR","GB00BDT5M118.USD","LU0345770308.USD","LU2272731782.SGD","LU0266013472.USD","FRNW","LU1023059063.AUD","LU0234572021.USD","LU1923622291.USD","LU2322448791.USD","LU1815333072.USD","IE00BFTCPJ56.SGD","IE00B1BXHZ80.USD","IE00BKPKM429.USD","LU1791710582.SGD","LU2264538146.SGD","LU2272731600.USD","LU2041044095.USD","LU1061106388.HKD","LU0823434740.USD","LU1720051108.HKD","LU2468319806.SGD","IE00BQXX3F31.USD","LAC","LU2089984988.USD","LU0957791311.USD","LU1670628061.USD","LU2211815571.USD","LU2125910179.SGD","LU2294711713.HKD","LU0320765489.SGD","LU1854103824.USD","LU0124384867.USD","LU1978683503.SGD","LU2322448957.HKD","LU1974910355.USD","LU1064131342.USD","LU1712237335.SGD","LU0823434583.USD","LU0432979614.USD","LU2357305700.SGD","IE00BGHQF417.EUR","LU2298322129.HKD","LU1983299246.USD","LU0122379950.USD","LU0823421333.USD","LU1291159041.SGD","LU2125909759.SGD","LU2764263203.CNY","LU1923622614.USD","LU0724618433.USD","TMO","FMED","LU1923621640.USD","BK4585","BK4094","LU2360108059.USD","HRTS","LU2125909593.SGD","IE00BJJMRZ35.SGD","LU0310800379.SGD","LU0823414551.USD","IE00B2B36J28.USD","LU0528227936.USD","IE00B19Z8X17.USD","BK4121","BK4588","LU0061474960.USD","LU1983299162.USD","LU0312595415.SGD","LU0048573561.USD","LU1633808545.USD","LU2106854487.HKD","LU2357125470.USD","GAP","LU1153585028.USD","IE00BQXX3C00.GBP","LU1917777945.USD","LU2506951792.HKD","LU2211814178.USD","LU1992135399.USD","LU2298321311.HKD","LU0640476718.USD","LU0742534661.SGD","BK4566","LU2272731865.HKD","LU2048586759.USD","LU1267930573.SGD","LACG","LU0316494557.USD","LU0251142724.SGD","ILIT","LU2433249047.HKD","SMOG","LU2063271972.USD","LU0128525929.USD","LU0345770993.USD","BK4545","LU0208291251.USD","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666577803","title":"Scholar Rock announces FDA approval of isembyld","url":"https://stock-news.laohu8.com/highlight/detail?id=2666577803","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666577803?lang=en_us&edition=fundamental","pubTime":"2026-09-12 06:30","pubTimestamp":1789165818,"startTime":"0","endTime":"0","summary":"Scholar Rock (SRRK) announced that the FDA has approved isembyld for the treatment of spinal muscular atrophy in adults and children two years of a...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/scholar-rock-announces-fda-approval-of-isembyld-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/scholar-rock-announces-fda-approval-of-isembyld-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IBB","MRNX","GDOC","IYH","FRTY","IEIH","LFSC","SRRK","BK4139","TECB","MEDI","NVIB","TBXU","BK4585","LABU","THNR","SYNB","RSPH","IDNA","GNMX","PINK","PSCH","MRNY","BMED","BK4588","BBP","XLVX","IBRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666957448","title":"Agilent Technologies Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2666957448","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666957448?lang=en_us&edition=fundamental","pubTime":"2026-09-12 04:53","pubTimestamp":1789159980,"startTime":"0","endTime":"0","summary":"DJ Agilent Technologies Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Agilent Technologies Inc.  rose 2.66% to $146.93 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index  rising 0.86% to 7,656.98 and the Dow Jones Industrial Average  rising 0.98% to 52,573.29.The stock's rise snapped a three-day losing streak.Agilent Technologies Inc. closed 10.27% short of its 52-week high of $163.75, which the company reached on August 27th.The stock outperformed some of its competitors Friday, as Thermo Fisher Scientific Inc.  rose 1.10% to $609.82, Danaher Corp.  fell 0.19% to $200.14, and Abbott Laboratories  fell 1.36% to $101.95.Trading volume  remained 382,080 below its 50-day average volume of 2.1 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 11, 2026.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1551013342.USD","LU0320765059.SGD","IE00B4R5TH58.HKD","LU1804176565.USD","LU1854103824.USD","LU0708995401.HKD","LU1815333072.USD","GNMX","HRTS","LU0175139822.USD","TMO","BK4533","LU0170899867.USD","LU1914381329.SGD","LU1988902786.USD","IE00BQXX3D17.EUR","LU1165135440.EUR","BK4082","TMED","LU0347712357.USD","LU1791710400.SGD","ABT","FMED","LU1974910355.USD","BK4588","IHI","LU0672654240.SGD","LU0390134368.USD","LU0187121727.USD","LU0266013472.USD","LU2041044095.USD","LU2264538146.SGD","LU0943347566.SGD","BK4567","PJP","LU2413666699.HKD","LU1280957306.USD","LU1543694498.USD","A","IE0004445239.USD","LU0689472784.USD","LU1691799644.USD","BK4585","LU0820561909.HKD","LU1721429741.USD","LU1064131342.USD","IE00BJJMRZ35.SGD","LU1623119135.USD","LU0122379950.USD","DHR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666579410","title":"IntegraGen receives rival takeover bids amid court‑ordered restructuring","url":"https://stock-news.laohu8.com/highlight/detail?id=2666579410","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666579410?lang=en_us&edition=fundamental","pubTime":"2026-09-12 03:02","pubTimestamp":1789153348,"startTime":"0","endTime":"0","summary":"IntegraGen SA ( ($FR:ALINT) ) has provided an update. IntegraGen SA, a French genomics company focused on cancer and rare genetic diseases, provide...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/integragen-receives-rival-takeover-bids-amid-courtordered-restructuring?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/integragen-receives-rival-takeover-bids-amid-courtordered-restructuring?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TARK","BMED","IDNA","DARP","GNOM","FWD","GNMX","PBE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666795715","title":"Pharming wins FDA nod to extend Joenja use to younger APDS children","url":"https://stock-news.laohu8.com/highlight/detail?id=2666795715","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666795715?lang=en_us&edition=fundamental","pubTime":"2026-09-12 02:32","pubTimestamp":1789151567,"startTime":"0","endTime":"0","summary":"Pharming Group ( ($NL:PHARM) ) has provided an announcement. Pharming has secured U.S. FDA approval for new 40 mg and 50 mg twice-daily doses of Jo...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/pharming-wins-fda-nod-to-extend-joenja-use-to-younger-apds-children?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/pharming-wins-fda-nod-to-extend-joenja-use-to-younger-apds-children?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IDNA","BK4585","PINK","NVIB","PSCH","TBXU","BK4588","IBB","MRNY","SYNB","GDOC","GNMX","BMED","XLVX","LFSC","LABU","IYH","FRTY","MEDI","TECB","RSPH","BBP","IEIH","MRNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666546340","title":"Vertex Minerals Confirms Reward Gold Mine Resource After ASX‑Driven Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2666546340","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666546340?lang=en_us&edition=fundamental","pubTime":"2026-09-11 13:57","pubTimestamp":1789106251,"startTime":"0","endTime":"0","summary":"Vertex Minerals Ltd. ( ($AU:VTX) ) just unveiled an update. Vertex Minerals has amended its previously released updated mineral resource estimate f...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vertex-minerals-confirms-reward-gold-mine-resource-after-asxdriven-update?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vertex-minerals-confirms-reward-gold-mine-resource-after-asxdriven-update?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2362541513.USD","LU2468319806.SGD","BK4585","IDNA","IE00B19Z9P08.USD","SGDJ","LU0256863811.USD","IBB","BIB","IE00BZ9MQY76.HKD","PBE","LU2462157665.USD","LU0320765992.SGD","LU2236285917.USD","VRTX","IE00B4R5TH58.HKD","LU2362540622.SGD","MTX","GNMX","LU0889565916.HKD","LU0417517546.SGD","LU1815336091.USD","LU1035775433.USD","LU2456880835.USD","IE00B19Z3B42.SGD","IE0002141913.USD","BK4109","LU2417539215.USD","IE00BJT1NW94.SGD","IE00B2B36J28.USD","LU0058720904.USD","SGXZ57979304.SGD","BK4588","LU1585245621.USD","TBXU","BBH","LU0109394709.USD","LU2362541273.HKD","BK4533","IE00B19Z9Z06.USD","BK4532","VERX","LU1559883803.SGD","LU2237438978.USD","IE00BFTCPJ56.SGD","BK4567","LU1093756325.SGD","SG9999001176.SGD","LU1778281490.HKD","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666601548","title":"Analysts Offer Insights on NA Companies: Expeditors International (EXPD) and Illumina (ILMN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2666601548","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666601548?lang=en_us&edition=fundamental","pubTime":"2026-09-11 11:30","pubTimestamp":1789097407,"startTime":"0","endTime":"0","summary":"Companies in the NA sector have received a lot of coverage today as analysts weigh in on Expeditors International (EXPD) and Illumina (ILMN). Exped...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-na-companies-expeditors-international-expd-and-illumina-ilmn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-na-companies-expeditors-international-expd-and-illumina-ilmn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GNMX","LU2506951958.HKD","HULL","BK4141","LU0823417653.USD","LU0823417737.USD","LU0128526141.USD","BK4548","BK4533","BK4585","BK4534","LU2506952097.USD","LU2506952170.USD","BK4567","BK4535","EXPD","NA","LU2506951875.HKD","ILMN","LU0950375773.USD","GNOM","BK4588","BK4131","BK4121","LU0029874061.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666515515","title":"Vertex Pharma EVP Jasper Van Grunsven Files Initial Beneficial Ownership Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2666515515","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666515515?lang=en_us&edition=fundamental","pubTime":"2026-09-11 04:16","pubTimestamp":1789071415,"startTime":"0","endTime":"0","summary":"Vertex Pharma EVP Jasper van Grunsven files initial beneficial ownership statementVertex Pharmaceuticals EVP Jasper van Grunsven filed an initial Form 3 insider ownership statement dated Sept. 8, 2026","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nNDL2ylbPY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2089984988.USD","IBBQ","LU1093756168.USD","IBB","IE00B894F039.SGD","IDNA","LU1430594728.SGD","BIB","LU2456880835.USD","IE00BFTCPJ56.SGD","IE0002270589.USD","LU1585245621.USD","LU1069344957.HKD","BBH","LU0889565916.HKD","IE00B19Z3B42.SGD","LU1674673691.USD","LU0320765992.SGD","LU0061475181.USD","LU2417539215.USD","LU2468319806.SGD","LU0289739699.SGD","IE00BJJMRZ35.SGD","LU2362540622.SGD","SG9999013999.USD","LU0256863811.USD","LU0058720904.USD","BK4585","LU2324357040.USD","BK4533","LU0432979614.USD","IE00B19Z3581.USD","LU0079474960.USD","SG9999001176.USD","SGXZ57979304.SGD","VRTX","IE0002141913.USD","LU2236285917.USD","BK4532","IE0009355771.USD","LU1035775433.USD","LU2237438978.USD","TBXU","LU1674673428.USD","LU0823416689.USD","LU0109394709.USD","IE00B2B36J28.USD","IE00B19Z9Z06.USD","GNMX","PBE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666939315","title":"Fortrea Reinstates Knoblauch as CFO After Legal Dispute with Former Employer","url":"https://stock-news.laohu8.com/highlight/detail?id=2666939315","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666939315?lang=en_us&edition=fundamental","pubTime":"2026-09-10 20:12","pubTimestamp":1789042320,"startTime":"0","endTime":"0","summary":"Fortrea Holdings reinstated Jason Knoblauch as chief financial officer following a legal dispute with his former employer.Knoblauch had initially joined the contract-research company in July. He was p","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0096362180.USD","LU1720051108.HKD","GNMX","LU0345770308.USD","LU2125910336.SGD","LU2468319806.SGD","FTRE","LU1291159041.SGD","LU0320765489.SGD","LU1988902786.USD","TMED","LU0342679015.USD","LU0742534661.SGD","LU1815333072.USD","BK4533","BK4585","LU0251142724.SGD","LU1623119135.USD","IE00BFTCPJ56.SGD","BK4121","BK4535","GB00BDT5M118.USD","LU1633808545.USD","LU0823416689.USD","LU2125910179.SGD","LU2063271972.USD","IE00B1BXHZ80.USD","LU0128525929.USD","LU2112291526.USD","LU2211815571.USD","TMO","LU0345770993.USD","LU0122379950.USD","IE00B19Z9505.USD","LU0528227936.USD","LU1854104046.USD","LU1989771016.USD","LU2298321311.HKD","LU0266013472.USD","BK4588","LU1280957306.USD","LU0061474960.USD","LU2764263203.CNY","HRTS","LU2041044095.USD","BK4581","BK4548","LU1923622291.USD","FMED","IE00B2B36J28.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666530163","title":"Bank of America Reveals 5.22% Indirect Stake in Qiagen","url":"https://stock-news.laohu8.com/highlight/detail?id=2666530163","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666530163?lang=en_us&edition=fundamental","pubTime":"2026-09-10 04:37","pubTimestamp":1788986261,"startTime":"0","endTime":"0","summary":"Qiagen ( ($QGEN) ) has issued an update. QIAGEN N.V., a Netherlands-based life sciences and biotechnology group focused on molecular diagnostics an...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bank-of-america-reveals-5-22-indirect-stake-in-qiagen?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bank-of-america-reveals-5-22-indirect-stake-in-qiagen?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HTEC","LU0256863811.USD","GNMX","LU1496350502.SGD","UYG","LU1718418525.SGD","LU0648000940.SGD","LU2133065610.SGD","HELX","VFH","FHLC","FWD","LNGR","TFNS","LU0208291251.USD","BAC","XLF","BMED","IEIH","SYNB","FNCL","PGF","LU1894683264.USD","IE00B1BXHZ80.USD","LU1804176565.USD","RSPH","LU0130517989.USD","LU1366192091.USD","IYG","LU0321505868.SGD","XT","JDOC","BBP","BK4534","IYF","IBB","LU0648001328.SGD","LU0070302665.USD","FTXO","LU0314106906.USD","LU1280957306.USD","DARP","BK4581","LU2129689431.USD","BK4582","AGNG","KBWB","LU0256863902.USD","IE00BKVL7J92.USD","IE00B19Z3581.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666365725","title":"Thermo Fisher Coverage Assumed by UBS at Buy vs Previous Rating of Neutral","url":"https://stock-news.laohu8.com/highlight/detail?id=2666365725","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666365725?lang=en_us&edition=fundamental","pubTime":"2026-09-09 21:40","pubTimestamp":1788961200,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TMO/analyst-ratings","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","IE00BJJMRZ35.SGD","LU1923621640.USD","LU1988902786.USD","LU2764263203.CNY","LU1064131342.USD","LU2125909247.SGD","LU2211815571.USD","LU0557290698.USD","LU2125910179.SGD","HRTS","LU2063271972.USD","LU1280957306.USD","LU1712237335.SGD","LU0122379950.USD","LU0070302665.USD","LU0708994859.HKD","BK4585","LU0114720955.EUR","LU2092937221.SGD","LU0128525929.USD","FMED","LU0208291251.USD","BK4581","IE00B19Z9505.USD","GB00BDT5M118.USD","LU2360108059.USD","TMED","LU2264538146.SGD","LU0310800379.SGD","LU0234572021.USD","GNMX","LU0029864427.USD","LU1633808545.USD","LU0345770993.USD","IE00B2B36J28.USD","LU0061474960.USD","LU1815333072.USD","LU1923622614.USD","BK4121","TMO","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","BK4566","LU1720051017.SGD","IE00BJT1NW94.SGD","LU0882574055.USD","LU2089984988.USD","BK4533","LU2125909593.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666368655","title":"UBS Adjusts Guardant Health Price Target to $225 From $175, Maintains Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2666368655","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666368655?lang=en_us&edition=fundamental","pubTime":"2026-09-09 21:35","pubTimestamp":1788960920,"startTime":"0","endTime":"0","summary":"Guardant Health (GH) has an average rating of buy and mean price target of $198.38, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major bank","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LFSC","GNOM","LU0889565916.HKD","HELX","EKG","BK4551","GNMX","LU0109394709.USD","PTH","GH","FFOX","BK4588","BK4585","LU0320765992.SGD","BK4535","BK4196","GDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666036370","title":"Thermo Fisher upgraded to Buy from Neutral at UBS","url":"https://stock-news.laohu8.com/highlight/detail?id=2666036370","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666036370?lang=en_us&edition=fundamental","pubTime":"2026-09-09 05:30","pubTimestamp":1788903011,"startTime":"0","endTime":"0","summary":"UBS upgraded Thermo Fisher (TMO) to Buy from Neutral with a price target of $730, up from $540. Published first on TheFly – the ultimate source for...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/thermo-fisher-upgraded-to-buy-from-neutral-at-ubs-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/thermo-fisher-upgraded-to-buy-from-neutral-at-ubs-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TMED","LU1720051017.SGD","IE00B2B36J28.USD","LU1064131342.USD","LU1291159041.SGD","LU1989771016.USD","LU2112291526.USD","BK4588","LU0528227936.USD","LU1988902786.USD","HRTS","LU1023059063.AUD","LU1548497426.USD","LU0742534661.SGD","LU1815333072.USD","LU2125910336.SGD","IE00B19Z8X17.USD","LU1623119135.USD","LU0128525929.USD","LU0342679015.USD","LU1923621640.USD","GNMX","LU0316494557.USD","LU2063271972.USD","BK4121","LU0557290698.USD","LU1803068623.USD","LU2125909593.SGD","LU2211815571.USD","TMO","LU2125909916.SGD","IE00BQXX3F31.USD","LU2264538146.SGD","FMED","LU1153585028.USD","LU0432979614.USD","LU1280957306.USD","LU2298321311.HKD","LU2357305700.SGD","BK4566","LU0320765489.SGD","LU1923622291.USD","BK4548","LU0251131958.USD","IE00BJJMRZ35.SGD","LU0011850046.USD","LU0029864427.USD","LU0345770308.USD","LU0061474960.USD","IE00BFTCPJ56.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666370651","title":"Steris PLC Stock Underperforms Tuesday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2666370651","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666370651?lang=en_us&edition=fundamental","pubTime":"2026-09-09 05:06","pubTimestamp":1788901560,"startTime":"0","endTime":"0","summary":"DJ Steris PLC Stock Underperforms Tuesday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Steris PLC  slipped 2.74% to $218.44 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index  falling 0.58% to 7,673.52 and Dow Jones Industrial Average  falling 1.18% to 52,786.07.This was the stock's third consecutive day of losses.Steris PLC closed 18.93% below its 52-week high of $269.44, which the company achieved on January 16th.The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Thermo Fisher Scientific Inc.  fell 1.75% to $603.02, Danaher Corp.  fell 1.17% to $205.23, and Becton Dickinson & Co.  fell 3.05% to $179.10.Data source: Dow Jones Market Data, FactSet. Data compiled September 8, 2026.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["STE","DHR","LU1153585028.USD","LU1803068623.USD","LU1892829315.USD","IE00BJT1NW94.SGD","LU0011850046.USD","LU0130103400.USD","LU0820561909.HKD","LU0390134368.USD","TMO","LU0689626769.HKD","LU1366333091.USD","TMED","IE00BQXX3F31.USD","BDX","SGXZ57979304.SGD","LU0708994859.HKD","LU1894683348.USD","LU1150488218.USD","HRTS","LU0048573561.USD","BK4535","LU2125909759.SGD","LU2764263039.SGD","BK4588","LU1623119135.USD","LU0130518102.USD","LU0251142724.SGD","LU1854103824.USD","FMED","LU0312595415.SGD","LU0162691827.USD","GNMX","LU0557290698.USD","LU2125909916.SGD","LU0128525929.USD","LU2125910336.SGD","LU2125909593.SGD","LU2720916845.USD","IE00BKVL7J92.USD","LU0006061336.USD","LU2023250504.SGD","IE00BZ1G4Q59.USD","LU0345770993.USD","LU2357305700.SGD","IHI","LU2264538146.SGD","LU0124676726.USD","LU1670628061.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666377632","title":"Structure weakness ‘disconnected’ from underlying data, says Jefferies","url":"https://stock-news.laohu8.com/highlight/detail?id=2666377632","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666377632?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:00","pubTimestamp":1788897615,"startTime":"0","endTime":"0","summary":"After Structure Therapeutics (GPCR) reported clinical trial results from its two lead product candidates, ACCG-2671 and aleniglipron, Jefferies see...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/structure-weakness-disconnected-from-underlying-data-says-jefferies-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/structure-weakness-disconnected-from-underlying-data-says-jefferies-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MRNY","GDOC","IDNA","PSIL","MEDI","SURI","PSCH","PTH","IEIH","BIB","BBH","FBT","BME","FTXH","PBE","CNCR","GNOM","LFSC","PJP","SYNB","CANC","JHMH","CURE","GNMX","IBRN","MDTX","PINK","IBBJ","TBXU","IBB","GPCR","FXH","BBP","IBBQ","AZNH","MEDX","XPH","SBIO","HYLG","LLYX","MNTL","APXH","RSPH","NVIB","PBPH","WDNA","JDOC","GSKH","FHLC","HRTS"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":6,"totalSize":200,"code":"91000000","status":"200"}]}}